Merck & Co., Inc.
MRKSEC CIK 310158Price charts ↗
Writing the earnings story…
Financials
Revenue+4.9% YoY
$16.29B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income-183.5% YoY
-$4.24B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)-185.6% YoY
-$1.72
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin
—
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
| Quarter ending | Revenue | Net income | EPS |
|---|---|---|---|
| Mar 2026 | $16.29B | -$4.24B | -$1.72 |
| Sep 2025 | $17.28B | $5.79B | $2.32 |
| Jun 2025 | $15.81B | $4.43B | $1.76 |
| Mar 2025 | $15.53B | $5.08B | $2.01 |
| Sep 2024 | $16.66B | $3.16B | $1.24 |
| Jun 2024 | $16.11B | $5.46B | $2.14 |
| Mar 2024 | $15.78B | $4.76B | $1.87 |
| Sep 2023 | $15.96B | $4.75B | $1.86 |
Annual revenue
FY21FY22FY23FY24FY25
Source filings
Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.
Quarterly report (10-Q)Filed 2026-05-04 · period ending 2026-03-31Open ↗Annual report (10-K)Filed 2026-02-24 · period ending 2025-12-31Open ↗Quarterly report (10-Q)Filed 2025-11-05 · period ending 2025-09-30Open ↗Quarterly report (10-Q)Filed 2025-08-05 · period ending 2025-06-30Open ↗Quarterly report (10-Q)Filed 2025-05-02 · period ending 2025-03-31Open ↗Annual report (10-K)Filed 2025-02-25 · period ending 2024-12-31Open ↗Quarterly report (10-Q)Filed 2024-11-06 · period ending 2024-09-30Open ↗Quarterly report (10-Q)Filed 2024-08-05 · period ending 2024-06-30Open ↗
Glossary
- Revenue
- Net income
- EPS
- Gross margin
- Net margin
- Fiscal year
Hover any underlined term for its definition.